Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

Davies, M., Heller, S. orcid.org/0000-0002-2425-9565, Sreenan, S. et al. (4 more authors) (2013) Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas. Diabetes Care, 36 (5). pp. 1368-1376. ISSN 0149-5992

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.
Dates:
  • Published: May 2013
  • Accepted: 5 November 2012
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 02 Dec 2016 14:04
Last Modified: 02 Dec 2016 14:04
Published Version: https://doi.org/10.2337/dc12-1333
Status: Published
Publisher: American Diabetes Association
Refereed: Yes
Identification Number: https://doi.org/10.2337/dc12-1333
Related URLs:

Share / Export

Statistics